Trial intelligence / Profile preview

Acoustic Coupling Fluid in Brain Tumor Surgery

NCT03181581Phase 2Terminated

Sponsor
St. Olavs University Hospital
Start
Mar 2017
Primary completion
Dec 2018
Countries
1
01

Overview

Phase 2, randomised, single-blind trial (4 arms), sponsored by St. Olavs University Hospital. Primary endpoint: Difference in serious adverse event rates at 6 months. Started Mar 2017; status: terminated.

Beyond the preview

Go deeper on NCT03181581.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03181581.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call